Literature DB >> 22372505

Cytokine network: new targeted therapy for pancreatic cancer.

Yoichi Matsuo1, Hiromitsu Takeyama, Sushovan Guha.   

Abstract

Increasing evidence has shown that cytokines have a role in tumor biology. The role of chemokines in tumor biology is important because these peptides may influence tumor growth, invasion, angiogenesis, and metastasis. In this review, we demonstrated the role of cytokines (Interleukin-1α, hepatocyte growth factor, Interleukin-8, stromal cell-derived factor-1 and CXC-chemokines/CXCR2 biological axis) in pancreatic cancer angiogenesis, especially from the standpoint of the interaction between tumor and its microenvironments. The cytokines are intimately related with cancer angiogenesis. Blocking these cytokines could attenuate pancreatic cancer associated angiogenesis and further considered as a novel anti-angiogenic target in pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22372505     DOI: 10.2174/13816128112092416

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  14 in total

1.  CXCR2 signaling promotes secretory cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.

Authors:  Mohammad Awaji; Sugandha Saxena; Lingyun Wu; Dipakkumar R Prajapati; Abhilasha Purohit; Michelle L Varney; Sushil Kumar; Satyanarayana Rachagani; Quan P Ly; Maneesh Jain; Surinder K Batra; Rakesh K Singh
Journal:  FASEB J       Date:  2020-05-26       Impact factor: 5.191

2.  Expression of CXCR2 and its clinical significance in human colorectal cancer.

Authors:  Wenjuan Wu; Changjiang Sun; Daoliang Xu; Xizhi Zhang; Weigan Shen; Ye Lv; Tao Ma
Journal:  Int J Clin Exp Med       Date:  2015-04-15

3.  Differential expression profile of CXC-receptor-2 ligands as potential biomarkers in pancreatic ductal adenocarcinoma.

Authors:  Sugandha Saxena; Caitlin Molczyk; Abhilasha Purohit; Evie Ehrhorn; Paran Goel; Dipakkumar R Prajapati; Pranita Atri; Sukhwinder Kaur; Paul M Grandgenett; Michael A Hollingsworth; Surinder K Batra; Rakesh K Singh
Journal:  Am J Cancer Res       Date:  2022-01-15       Impact factor: 6.166

4.  Selected cytokines in patients with pancreatic cancer: a preliminary report.

Authors:  Wojciech Błogowski; Anna Deskur; Marta Budkowska; Daria Sałata; Anna Madej-Michniewicz; Krzysztof Dąbkowski; Barbara Dołęgowska; Teresa Starzyńska
Journal:  PLoS One       Date:  2014-05-21       Impact factor: 3.240

5.  Localized interleukin-12 delivery for immunotherapy of solid tumours.

Authors:  Louis Z Wei; Yixin Xu; E Megan Nelles; Caren Furlonger; James C M Wang; Marco A Di Grappa; Rama Khokha; Jeffrey A Medin; Christopher J Paige
Journal:  J Cell Mol Med       Date:  2013-11-19       Impact factor: 5.310

6.  Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy.

Authors:  Qian Chen; Ligeng Xu; Chao Liang; Chao Wang; Rui Peng; Zhuang Liu
Journal:  Nat Commun       Date:  2016-10-21       Impact factor: 14.919

Review 7.  Current Prospects for Treatment of Solid Tumors via Photodynamic, Photothermal, or Ionizing Radiation Therapies Combined with Immune Checkpoint Inhibition (A Review).

Authors:  Sanjay Anand; Timothy A Chan; Tayyaba Hasan; Edward V Maytin
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-10

8.  Inflammation to cancer: The molecular biology in the pancreas (Review).

Authors:  Sunbin Ling; Tingting Feng; Kaiqi Jia; Yu Tian; Yan Li
Journal:  Oncol Lett       Date:  2014-03-28       Impact factor: 2.967

9.  CCL18 from ascites promotes ovarian cancer cell migration through proline-rich tyrosine kinase 2 signaling.

Authors:  Denis Lane; Isabelle Matte; Claude Laplante; Perrine Garde-Granger; Alex Carignan; Paul Bessette; Claudine Rancourt; Alain Piché
Journal:  Mol Cancer       Date:  2016-09-09       Impact factor: 27.401

10.  CCL18 from tumor-cells promotes epithelial ovarian cancer metastasis via mTOR signaling pathway.

Authors:  Qi Wang; Yong Tang; Hongjing Yu; Qiaoyun Yin; Mengdi Li; Lijun Shi; Wei Zhang; Danrong Li; Li Li
Journal:  Mol Carcinog       Date:  2015-10-12       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.